IVIG Versus Placebo for the Treatment of Patients With Severe C-Diff
This study has been terminated.
(We were unable to receive IVIG free from phamaceutical company.)
Sponsor:
University of Pittsburgh
Collaborators:
Shadyside Hospital Foundation
Bayer
Information provided by (Responsible Party):
Mary Beaves, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT00177970
First received: September 13, 2005
Last updated: January 16, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | April 2008 |
| Primary Completion Date: | April 2008 (Final data collection date for primary outcome measure) |